The change of plasma metabolic profile and gut microbiome dysbiosis in patients with rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic inflammatory joint disease, which is associated with progressive disability, systemic complications, and early death. But its etiology and pathogenesis are not fully understood. We aimed to investigate the alterations in plasma metabolite profiles, gut bacteria...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 13; p. 931431
Main Authors Zhu, Jing, Wang, Tingting, Lin, Yifei, Xiong, Minghao, Chen, Jianghua, Jian, Congcong, Zhang, Jie, Xie, Huanhuan, Zeng, Fanwei, Huang, Qian, Su, Jiang, Zhao, Yi, Li, Shilin, Zeng, Fanxin
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 18.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Rheumatoid arthritis (RA) is a chronic inflammatory joint disease, which is associated with progressive disability, systemic complications, and early death. But its etiology and pathogenesis are not fully understood. We aimed to investigate the alterations in plasma metabolite profiles, gut bacteria, and fungi and their role of them in the pathogenesis of RA.ObjectiveRheumatoid arthritis (RA) is a chronic inflammatory joint disease, which is associated with progressive disability, systemic complications, and early death. But its etiology and pathogenesis are not fully understood. We aimed to investigate the alterations in plasma metabolite profiles, gut bacteria, and fungi and their role of them in the pathogenesis of RA.Metabolomics profiling of plasma from 363 participants including RA (n = 244), systemic lupus erythematosus (SLE, n = 50), and healthy control (HC, n = 69) were performed using the ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry. The differentially expressed metabolites were selected among groups and used to explore important metabolic pathways. Gut microbial diversity analysis was performed by 16S rRNA sequencing and ITS sequencing (RA = 195, HC = 269), and the specific microbial floras were identified afterward. The diagnosis models were established based on significant differential metabolites and microbial floras, respectively.MethodsMetabolomics profiling of plasma from 363 participants including RA (n = 244), systemic lupus erythematosus (SLE, n = 50), and healthy control (HC, n = 69) were performed using the ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry. The differentially expressed metabolites were selected among groups and used to explore important metabolic pathways. Gut microbial diversity analysis was performed by 16S rRNA sequencing and ITS sequencing (RA = 195, HC = 269), and the specific microbial floras were identified afterward. The diagnosis models were established based on significant differential metabolites and microbial floras, respectively.There were 63 differential metabolites discovered between RA and HC groups, mainly significantly enriched in the arginine and proline metabolism, glycine, serine, and threonine metabolism, and glycerophospholipid metabolism between RA and HC groups. The core differential metabolites included L-arginine, creatine, D-proline, ornithine, choline, betaine, L-threonine, LysoPC (18:0), phosphorylcholine, and glycerophosphocholine. The L-arginine and phosphorylcholine were increased in the RA group. The AUC of the predictive model was 0.992, based on the combination of the 10 differential metabolites. Compared with the SLE group, 23 metabolites increased and 61 metabolites decreased in the RA group. However, no significant metabolic pathways were enriched between RA and SLE groups. On the genus level, a total of 117 differential bacteria genera and 531 differential fungal genera were identified between RA and HC groups. The results indicated that three bacteria genera (Eubacterium_hallii_group, Escherichia-Shigella, Streptococcus) and two fungal genera (Candida and Debaryomyces) significantly increased in RA patients. The AUC was 0.80 based on a combination of six differential bacterial genera and the AUC was 0.812 based on a combination of seven differential fungal genera. Functional predictive analysis displayed that differential bacterial and differential fungus both were associated with KEGG pathways involving superpathway of L-serine and glycine biosynthesis I, arginine, ornithine, and proline interconversion.ResultsThere were 63 differential metabolites discovered between RA and HC groups, mainly significantly enriched in the arginine and proline metabolism, glycine, serine, and threonine metabolism, and glycerophospholipid metabolism between RA and HC groups. The core differential metabolites included L-arginine, creatine, D-proline, ornithine, choline, betaine, L-threonine, LysoPC (18:0), phosphorylcholine, and glycerophosphocholine. The L-arginine and phosphorylcholine were increased in the RA group. The AUC of the predictive model was 0.992, based on the combination of the 10 differential metabolites. Compared with the SLE group, 23 metabolites increased and 61 metabolites decreased in the RA group. However, no significant metabolic pathways were enriched between RA and SLE groups. On the genus level, a total of 117 differential bacteria genera and 531 differential fungal genera were identified between RA and HC groups. The results indicated that three bacteria genera (Eubacterium_hallii_group, Escherichia-Shigella, Streptococcus) and two fungal genera (Candida and Debaryomyces) significantly increased in RA patients. The AUC was 0.80 based on a combination of six differential bacterial genera and the AUC was 0.812 based on a combination of seven differential fungal genera. Functional predictive analysis displayed that differential bacterial and differential fungus both were associated with KEGG pathways involving superpathway of L-serine and glycine biosynthesis I, arginine, ornithine, and proline interconversion.The plasma metabolism profile and gut microbe profile changed markedly in RA. The glycine, serine, and threonine metabolism and arginine and proline metabolism played an important role in RA.ConclusionThe plasma metabolism profile and gut microbe profile changed markedly in RA. The glycine, serine, and threonine metabolism and arginine and proline metabolism played an important role in RA.
AbstractList ObjectiveRheumatoid arthritis (RA) is a chronic inflammatory joint disease, which is associated with progressive disability, systemic complications, and early death. But its etiology and pathogenesis are not fully understood. We aimed to investigate the alterations in plasma metabolite profiles, gut bacteria, and fungi and their role of them in the pathogenesis of RA.MethodsMetabolomics profiling of plasma from 363 participants including RA (n = 244), systemic lupus erythematosus (SLE, n = 50), and healthy control (HC, n = 69) were performed using the ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry. The differentially expressed metabolites were selected among groups and used to explore important metabolic pathways. Gut microbial diversity analysis was performed by 16S rRNA sequencing and ITS sequencing (RA = 195, HC = 269), and the specific microbial floras were identified afterward. The diagnosis models were established based on significant differential metabolites and microbial floras, respectively.ResultsThere were 63 differential metabolites discovered between RA and HC groups, mainly significantly enriched in the arginine and proline metabolism, glycine, serine, and threonine metabolism, and glycerophospholipid metabolism between RA and HC groups. The core differential metabolites included L-arginine, creatine, D-proline, ornithine, choline, betaine, L-threonine, LysoPC (18:0), phosphorylcholine, and glycerophosphocholine. The L-arginine and phosphorylcholine were increased in the RA group. The AUC of the predictive model was 0.992, based on the combination of the 10 differential metabolites. Compared with the SLE group, 23 metabolites increased and 61 metabolites decreased in the RA group. However, no significant metabolic pathways were enriched between RA and SLE groups. On the genus level, a total of 117 differential bacteria genera and 531 differential fungal genera were identified between RA and HC groups. The results indicated that three bacteria genera (Eubacterium_hallii_group, Escherichia-Shigella, Streptococcus) and two fungal genera (Candida and Debaryomyces) significantly increased in RA patients. The AUC was 0.80 based on a combination of six differential bacterial genera and the AUC was 0.812 based on a combination of seven differential fungal genera. Functional predictive analysis displayed that differential bacterial and differential fungus both were associated with KEGG pathways involving superpathway of L-serine and glycine biosynthesis I, arginine, ornithine, and proline interconversion.ConclusionThe plasma metabolism profile and gut microbe profile changed markedly in RA. The glycine, serine, and threonine metabolism and arginine and proline metabolism played an important role in RA.
Rheumatoid arthritis (RA) is a chronic inflammatory joint disease, which is associated with progressive disability, systemic complications, and early death. But its etiology and pathogenesis are not fully understood. We aimed to investigate the alterations in plasma metabolite profiles, gut bacteria, and fungi and their role of them in the pathogenesis of RA.ObjectiveRheumatoid arthritis (RA) is a chronic inflammatory joint disease, which is associated with progressive disability, systemic complications, and early death. But its etiology and pathogenesis are not fully understood. We aimed to investigate the alterations in plasma metabolite profiles, gut bacteria, and fungi and their role of them in the pathogenesis of RA.Metabolomics profiling of plasma from 363 participants including RA (n = 244), systemic lupus erythematosus (SLE, n = 50), and healthy control (HC, n = 69) were performed using the ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry. The differentially expressed metabolites were selected among groups and used to explore important metabolic pathways. Gut microbial diversity analysis was performed by 16S rRNA sequencing and ITS sequencing (RA = 195, HC = 269), and the specific microbial floras were identified afterward. The diagnosis models were established based on significant differential metabolites and microbial floras, respectively.MethodsMetabolomics profiling of plasma from 363 participants including RA (n = 244), systemic lupus erythematosus (SLE, n = 50), and healthy control (HC, n = 69) were performed using the ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry. The differentially expressed metabolites were selected among groups and used to explore important metabolic pathways. Gut microbial diversity analysis was performed by 16S rRNA sequencing and ITS sequencing (RA = 195, HC = 269), and the specific microbial floras were identified afterward. The diagnosis models were established based on significant differential metabolites and microbial floras, respectively.There were 63 differential metabolites discovered between RA and HC groups, mainly significantly enriched in the arginine and proline metabolism, glycine, serine, and threonine metabolism, and glycerophospholipid metabolism between RA and HC groups. The core differential metabolites included L-arginine, creatine, D-proline, ornithine, choline, betaine, L-threonine, LysoPC (18:0), phosphorylcholine, and glycerophosphocholine. The L-arginine and phosphorylcholine were increased in the RA group. The AUC of the predictive model was 0.992, based on the combination of the 10 differential metabolites. Compared with the SLE group, 23 metabolites increased and 61 metabolites decreased in the RA group. However, no significant metabolic pathways were enriched between RA and SLE groups. On the genus level, a total of 117 differential bacteria genera and 531 differential fungal genera were identified between RA and HC groups. The results indicated that three bacteria genera (Eubacterium_hallii_group, Escherichia-Shigella, Streptococcus) and two fungal genera (Candida and Debaryomyces) significantly increased in RA patients. The AUC was 0.80 based on a combination of six differential bacterial genera and the AUC was 0.812 based on a combination of seven differential fungal genera. Functional predictive analysis displayed that differential bacterial and differential fungus both were associated with KEGG pathways involving superpathway of L-serine and glycine biosynthesis I, arginine, ornithine, and proline interconversion.ResultsThere were 63 differential metabolites discovered between RA and HC groups, mainly significantly enriched in the arginine and proline metabolism, glycine, serine, and threonine metabolism, and glycerophospholipid metabolism between RA and HC groups. The core differential metabolites included L-arginine, creatine, D-proline, ornithine, choline, betaine, L-threonine, LysoPC (18:0), phosphorylcholine, and glycerophosphocholine. The L-arginine and phosphorylcholine were increased in the RA group. The AUC of the predictive model was 0.992, based on the combination of the 10 differential metabolites. Compared with the SLE group, 23 metabolites increased and 61 metabolites decreased in the RA group. However, no significant metabolic pathways were enriched between RA and SLE groups. On the genus level, a total of 117 differential bacteria genera and 531 differential fungal genera were identified between RA and HC groups. The results indicated that three bacteria genera (Eubacterium_hallii_group, Escherichia-Shigella, Streptococcus) and two fungal genera (Candida and Debaryomyces) significantly increased in RA patients. The AUC was 0.80 based on a combination of six differential bacterial genera and the AUC was 0.812 based on a combination of seven differential fungal genera. Functional predictive analysis displayed that differential bacterial and differential fungus both were associated with KEGG pathways involving superpathway of L-serine and glycine biosynthesis I, arginine, ornithine, and proline interconversion.The plasma metabolism profile and gut microbe profile changed markedly in RA. The glycine, serine, and threonine metabolism and arginine and proline metabolism played an important role in RA.ConclusionThe plasma metabolism profile and gut microbe profile changed markedly in RA. The glycine, serine, and threonine metabolism and arginine and proline metabolism played an important role in RA.
Author Wang, Tingting
Chen, Jianghua
Jian, Congcong
Zhao, Yi
Li, Shilin
Zhu, Jing
Su, Jiang
Lin, Yifei
Xiong, Minghao
Huang, Qian
Zhang, Jie
Xie, Huanhuan
Zeng, Fanxin
Zeng, Fanwei
AuthorAffiliation 4 Precision Medicine Center, West China Hospital, Sichuan University , Chengdu , China
6 School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine , Chengdu , China
3 Department of Clinical Research Center, Dazhou Central Hospital , Dazhou , China
2 Department of Rheumatology and Immunology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China , Chengdu , China
8 Dazhou Vocational and Technical College , Dazhou , China
9 Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Clinical Institute of Inflammation and Immunology, Sichuan University , Chengdu , China
5 North Sichuan Medical College , Nanchong , China
1 Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu , China
7 Sichuan Province Orthopaedic Hospital , Chengdu , China
AuthorAffiliation_xml – name: 9 Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Clinical Institute of Inflammation and Immunology, Sichuan University , Chengdu , China
– name: 3 Department of Clinical Research Center, Dazhou Central Hospital , Dazhou , China
– name: 1 Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu , China
– name: 5 North Sichuan Medical College , Nanchong , China
– name: 4 Precision Medicine Center, West China Hospital, Sichuan University , Chengdu , China
– name: 6 School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine , Chengdu , China
– name: 2 Department of Rheumatology and Immunology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China , Chengdu , China
– name: 7 Sichuan Province Orthopaedic Hospital , Chengdu , China
– name: 8 Dazhou Vocational and Technical College , Dazhou , China
Author_xml – sequence: 1
  givenname: Jing
  surname: Zhu
  fullname: Zhu, Jing
– sequence: 2
  givenname: Tingting
  surname: Wang
  fullname: Wang, Tingting
– sequence: 3
  givenname: Yifei
  surname: Lin
  fullname: Lin, Yifei
– sequence: 4
  givenname: Minghao
  surname: Xiong
  fullname: Xiong, Minghao
– sequence: 5
  givenname: Jianghua
  surname: Chen
  fullname: Chen, Jianghua
– sequence: 6
  givenname: Congcong
  surname: Jian
  fullname: Jian, Congcong
– sequence: 7
  givenname: Jie
  surname: Zhang
  fullname: Zhang, Jie
– sequence: 8
  givenname: Huanhuan
  surname: Xie
  fullname: Xie, Huanhuan
– sequence: 9
  givenname: Fanwei
  surname: Zeng
  fullname: Zeng, Fanwei
– sequence: 10
  givenname: Qian
  surname: Huang
  fullname: Huang, Qian
– sequence: 11
  givenname: Jiang
  surname: Su
  fullname: Su, Jiang
– sequence: 12
  givenname: Yi
  surname: Zhao
  fullname: Zhao, Yi
– sequence: 13
  givenname: Shilin
  surname: Li
  fullname: Li, Shilin
– sequence: 14
  givenname: Fanxin
  surname: Zeng
  fullname: Zeng, Fanxin
BookMark eNp1kU1v1DAQhiNUJErpD-DmI5ddHI_z4QsSqvioVInLHrhZE39spkriYDug_nu83SJRJHywR_a8z4znfV1dLGFxVfW25nuAXr33M5lhL7gQewW1hPpFdVm3rdwBF98v_opfVdcp3fOyJBdlv6zoMDpmRlyOjgXP1gnTjGx2GYcwkWFrDJ4mx3Cx7LhlVirFMFCYHbMPqQSJEqOFrZjJLTmxX5RHFke3zZgDWYYxj5EypTfVS49TctdP51V1-PzpcPN1d_fty-3Nx7udkVLkneeOG9X31kMHlqPBxjSy8RIAewNtz3uwvoTKKuPBcWWt8h58a3xnW7iqbs9YG_Ber5FmjA86IOnHixCPurREZnK6H3poazNIyQcpGkTsQNVDp1qpJLeisD6cWes2zM6a8sGI0zPo85eFRn0MP7VqBbQdFMC7J0AMPzaXsp4pGTdNuLiwJS06EE3poTmldufUMt-UovPaUC5DDScyTbrm-uS1fvRan7zWZ6-Lsv5H-afB_2t-A97gsyk
CitedBy_id crossref_primary_10_1016_j_jep_2023_116542
crossref_primary_10_3389_fimmu_2024_1381272
crossref_primary_10_3389_fmolb_2023_1281987
crossref_primary_10_1186_s13075_023_03208_2
crossref_primary_10_3390_ijms24065161
crossref_primary_10_1002_acr2_11604
crossref_primary_10_1016_j_arcmed_2023_102907
crossref_primary_10_1111_1756_185X_15447
crossref_primary_10_3389_fmicb_2024_1431367
crossref_primary_10_3390_biom14040392
crossref_primary_10_3389_fmed_2023_1174331
crossref_primary_10_1186_s13075_024_03423_5
crossref_primary_10_1016_j_rdc_2025_01_004
Cites_doi 10.7554/eLife.01202
10.1016/j.jneuroim.2015.01.001
10.1016/j.atherosclerosis.2017.10.004
10.1186/s13073-016-0299-7
10.1038/cddis.2015.246
10.1111/nmo.12366
10.1111/1756-185X.13802
10.1186/ar4480
10.1038/s41467-020-14285-1
10.1038/srep30594
10.4161/gmic.19320
10.1002/art.1780400928
10.1038/nrdp.2018.1
10.1186/s13075-018-1655-3
10.1576/toag.13.3.189.27672
10.1007/s12035-019-01721-7
10.1126/scitranslmed.aaa0835
10.1172/JCI32639
10.1136/ard.62.10.976
10.1111/j.0954-6820.1968.tb02478.x
10.1371/journal.pone.0163087
10.1186/s13075-018-1729-2
10.1002/art.37921
10.1002/art.34473
10.1038/nature18646
10.1007/s00441-014-2036-0
10.1136/annrheumdis-2019-216655
10.1093/ijnp/pyv114
10.1136/gutjnl-2019-319766
10.1016/j.jpba.2019.113068
10.4161/cc.26067
10.1016/S0140-6736(16)30173-8
10.3389/fphar.2018.00282
10.1016/j.febslet.2014.05.034
10.1038/ni.3323
10.1371/journal.pone.0138537
10.1038/s41392-020-00443-w
10.1002/ijc.32007
10.1111/j.1462-2920.2009.02066.x
10.3389/fphar.2018.01051
10.1371/journal.pone.0224730
10.1126/science.abd0919
10.1136/annrheumdis-2019-215743
10.1186/s13075-020-02405-7
10.1136/annrheumdis-2014-205696
10.1177/0961203311418707
10.1002/art.11282
10.1093/rheumatology/kes279
10.1016/j.intimp.2019.01.018
10.1007/s11033-010-0545-9
ContentType Journal Article
Copyright Copyright © 2022 Zhu, Wang, Lin, Xiong, Chen, Jian, Zhang, Xie, Zeng, Huang, Su, Zhao, Li and Zeng.
Copyright © 2022 Zhu, Wang, Lin, Xiong, Chen, Jian, Zhang, Xie, Zeng, Huang, Su, Zhao, Li and Zeng. 2022 Zhu, Wang, Lin, Xiong, Chen, Jian, Zhang, Xie, Zeng, Huang, Su, Zhao, Li and Zeng
Copyright_xml – notice: Copyright © 2022 Zhu, Wang, Lin, Xiong, Chen, Jian, Zhang, Xie, Zeng, Huang, Su, Zhao, Li and Zeng.
– notice: Copyright © 2022 Zhu, Wang, Lin, Xiong, Chen, Jian, Zhang, Xie, Zeng, Huang, Su, Zhao, Li and Zeng. 2022 Zhu, Wang, Lin, Xiong, Chen, Jian, Zhang, Xie, Zeng, Huang, Su, Zhao, Li and Zeng
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fmicb.2022.931431
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-302X
ExternalDocumentID oai_doaj_org_article_8b8361cb440b425aaa7391b7964940d2
PMC9623673
10_3389_fmicb_2022_931431
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
ECGQY
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
PGMZT
RNS
RPM
7X8
5PM
ID FETCH-LOGICAL-c442t-f0e0c988df373d0aca5c545f433a8c368083dfa8c9d9cf3e09dd9ff3f6cf7d63
IEDL.DBID DOA
ISSN 1664-302X
IngestDate Wed Aug 27 01:32:10 EDT 2025
Thu Aug 21 18:38:29 EDT 2025
Fri Jul 11 02:40:36 EDT 2025
Thu Apr 24 22:56:53 EDT 2025
Tue Jul 01 01:39:43 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c442t-f0e0c988df373d0aca5c545f433a8c368083dfa8c9d9cf3e09dd9ff3f6cf7d63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Shulan Su, Nanjing University of Chinese Medicine, China; Zhu Chen, University of Science and Technology of China, China
These authors have contributed equally to this work
This article was submitted to Microbial Symbioses, a section of the journal Frontiers in Microbiology
Edited by: Cong-Qiu Chu, Oregon Health and Science University, United States
OpenAccessLink https://doaj.org/article/8b8361cb440b425aaa7391b7964940d2
PQID 2732536153
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_8b8361cb440b425aaa7391b7964940d2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9623673
proquest_miscellaneous_2732536153
crossref_citationtrail_10_3389_fmicb_2022_931431
crossref_primary_10_3389_fmicb_2022_931431
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-10-18
PublicationDateYYYYMMDD 2022-10-18
PublicationDate_xml – month: 10
  year: 2022
  text: 2022-10-18
  day: 18
PublicationDecade 2020
PublicationTitle Frontiers in microbiology
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Kay (B20) 2012; 51
Song (B40) 2020; 180
Smolen (B39) 2020; 79
Scher (B35) 2013; 2
Zeng (B50) 2019; 14
Pedersen (B30) 2016; 535
Taneja (B41) 2014; 588
Priori (B32) 2015; 10
Grover (B11) 2014; 26
Mun (B25) 2021; 23
Simelyte (B36) 2003; 62
Wang (B46) 2018; 9
Kishikawa (B21) 2020; 79
Narasimhan (B27) 2018; 20
Brunner (B4) 2020; 11
Foster (B10) 2016; 19
Tang (B42) 2020; 57
Cuppen (B8) 2016; 11
Teitsma (B43) 2018; 20
Abdollahi-Roodsaz (B1) 2008; 118
Guma (B12) 2015; 74
Smolen (B38) 2018; 4
Smolen (B37) 2016; 388
Hochberg (B13) 1997; 40
Louis (B23) 2010; 12
Liu (B22) 2016; 6
Luckey (B24) 2013; 138
Petri (B31) 2012; 64
Horgan (B14) 2011; 13
Ouyang (B29) 2011; 20
Jain (B17) 2021; 371
Kapoor (B19) 2013; 65
Roivainen (B34) 2003; 48
Kang (B18) 2015; 279
Radhakutty (B33) 2017; 266
Bishu (B3) 2014; 16
Wang (B45) 2021; 6
Zhang (B51) 2018; 9
Olhagen (B28) 1968; 184
Yin (B49) 2015; 7
Hui (B16) 2019; 68
Chimenti (B6) 2015; 6
Murray (B26) 2016; 17
Wang (B44); 23
Wang (B47); 69
Chimenti (B7) 2013; 12
Chen (B5) 2016; 8
Hu (B15) 2011; 38
Beckmann (B2) 2015; 359
Wu (B48) 2012; 3
Feng (B9) 2019; 144
References_xml – volume: 2
  year: 2013
  ident: B35
  article-title: Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis.
  publication-title: Elife
  doi: 10.7554/eLife.01202
– volume: 279
  start-page: 25
  year: 2015
  ident: B18
  article-title: Application of metabolomics in autoimmune diseases: Insight into biomarkers and pathology.
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2015.01.001
– volume: 266
  start-page: 190
  year: 2017
  ident: B33
  article-title: Opposing effects of rheumatoid arthritis and low dose prednisolone on arginine metabolomics.
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2017.10.004
– volume: 8
  year: 2016
  ident: B5
  article-title: An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis.
  publication-title: Genome Med.
  doi: 10.1186/s13073-016-0299-7
– volume: 6
  year: 2015
  ident: B6
  article-title: The interplay between inflammation and metabolism in rheumatoid arthritis.
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2015.246
– volume: 26
  start-page: 745
  year: 2014
  ident: B11
  article-title: Germ-free mice as a model to study effect of gut microbiota on host physiology.
  publication-title: Neurogastroenterol. Motil.
  doi: 10.1111/nmo.12366
– volume: 23
  start-page: 472
  ident: B44
  article-title: Alteration of the gut microbiota in tumor necrosis factor-alpha antagonist-treated collagen-induced arthritis mice.
  publication-title: Int. J. Rheum. Dis.
  doi: 10.1111/1756-185X.13802
– volume: 16
  year: 2014
  ident: B3
  article-title: Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses.
  publication-title: Arthritis. Res. Ther.
  doi: 10.1186/ar4480
– volume: 11
  year: 2020
  ident: B4
  article-title: Environmental arginine controls multinuclear giant cell metabolism and formation.
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-14285-1
– volume: 6
  year: 2016
  ident: B22
  article-title: Role of the gut microbiome in modulating arthritis progression in mice.
  publication-title: Sci. Rep.
  doi: 10.1038/srep30594
– volume: 3
  start-page: 4
  year: 2012
  ident: B48
  article-title: The role of gut microbiota in immune homeostasis and autoimmunity.
  publication-title: Gut Microbes.
  doi: 10.4161/gmic.19320
– volume: 40
  year: 1997
  ident: B13
  article-title: Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus.
  publication-title: Arthritis. Rheum.
  doi: 10.1002/art.1780400928
– volume: 4
  year: 2018
  ident: B38
  article-title: Rheumatoid arthritis.
  publication-title: Nat. Rev. Dis. Primers
  doi: 10.1038/nrdp.2018.1
– volume: 20
  year: 2018
  ident: B27
  article-title: Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis.
  publication-title: Arthritis Res. Ther.
  doi: 10.1186/s13075-018-1655-3
– volume: 13
  start-page: 189
  year: 2011
  ident: B14
  article-title: Omic technologies: Genomics, transcriptomics, proteomics and metabolomics.
  publication-title: Obstetr. Gynaecol.
  doi: 10.1576/toag.13.3.189.27672
– volume: 57
  start-page: 461
  year: 2020
  ident: B42
  article-title: gut microbiota dysbiosis enhances migraine-like pain via TNFalpha upregulation.
  publication-title: Mol. Neurobiol.
  doi: 10.1007/s12035-019-01721-7
– volume: 7
  year: 2015
  ident: B49
  article-title: Normalization of CD4+ T cell metabolism reverses lupus.
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aaa0835
– volume: 118
  start-page: 205
  year: 2008
  ident: B1
  article-title: Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI32639
– volume: 62
  start-page: 976
  year: 2003
  ident: B36
  article-title: Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis.
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/ard.62.10.976
– volume: 184
  start-page: 395
  year: 1968
  ident: B28
  article-title: Intestinal Clostridium perfringens in rheumatoid arthritis and other collagen diseases.
  publication-title: Acta Med. Scand.
  doi: 10.1111/j.0954-6820.1968.tb02478.x
– volume: 11
  year: 2016
  ident: B8
  article-title: Exploring the inflammatory metabolomic profile to predict response to TNF-alpha Inhibitors in rheumatoid arthritis.
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0163087
– volume: 20
  year: 2018
  ident: B43
  article-title: Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: Insights from systems biology.
  publication-title: Arthritis Res. Ther.
  doi: 10.1186/s13075-018-1729-2
– volume: 65
  start-page: 1448
  year: 2013
  ident: B19
  article-title: Metabolic profiling predicts response to anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis.
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.37921
– volume: 64
  start-page: 2677
  year: 2012
  ident: B31
  article-title: Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.34473
– volume: 535
  start-page: 376
  year: 2016
  ident: B30
  article-title: Human gut microbes impact host serum metabolome and insulin sensitivity.
  publication-title: Nature
  doi: 10.1038/nature18646
– volume: 359
  start-page: 465
  year: 2015
  ident: B2
  article-title: Expression of choline and acetylcholine transporters in synovial tissue and cartilage of patients with rheumatoid arthritis and osteoarthritis.
  publication-title: Cell Tissue Res.
  doi: 10.1007/s00441-014-2036-0
– volume: 79
  start-page: 685
  year: 2020
  ident: B39
  article-title: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/annrheumdis-2019-216655
– volume: 19
  year: 2016
  ident: B10
  article-title: Gut microbiota and brain function: An evolving field in neuroscience.
  publication-title: Int. J. Neuropsychopharmacol.
  doi: 10.1093/ijnp/pyv114
– volume: 69
  start-page: 2131
  ident: B47
  article-title: Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents.
  publication-title: Gut
  doi: 10.1136/gutjnl-2019-319766
– volume: 180
  year: 2020
  ident: B40
  article-title: Untargeted metabolomics reveals novel serum biomarker of renal damage in rheumatoid arthritis.
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2019.113068
– volume: 138
  start-page: 732
  year: 2013
  ident: B24
  article-title: Bugs & us: The role of the gut in autoimmunity.
  publication-title: Indian J Med Res
– volume: 12
  start-page: 3025
  year: 2013
  ident: B7
  article-title: Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-alpha infliximab.
  publication-title: Cell Cycle
  doi: 10.4161/cc.26067
– volume: 388
  start-page: 2023
  year: 2016
  ident: B37
  article-title: Rheumatoid arthritis.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)30173-8
– volume: 9
  year: 2018
  ident: B51
  article-title: Comparative Metabolomics Analysis of Cervicitis in Human Patients and a Phenol Mucilage-Induced Rat Model Using Liquid Chromatography Tandem Mass Spectrometry.
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2018.00282
– volume: 588
  start-page: 4244
  year: 2014
  ident: B41
  article-title: Arthritis susceptibility and the gut microbiome.
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2014.05.034
– volume: 17
  start-page: 132
  year: 2016
  ident: B26
  article-title: Amino acid auxotrophy as a system of immunological control nodes.
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3323
– volume: 10
  year: 2015
  ident: B32
  article-title: (1)H-NMR-Based metabolomic study for identifying serum profiles associated with the response to etanercept in patients with rheumatoid arthritis.
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0138537
– volume: 6
  year: 2021
  ident: B45
  article-title: Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets.
  publication-title: Signal Transduct. Target Ther.
  doi: 10.1038/s41392-020-00443-w
– volume: 144
  start-page: 2728
  year: 2019
  ident: B9
  article-title: Alterations in the gut microbiota and metabolite profiles of thyroid carcinoma patients.
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.32007
– volume: 12
  start-page: 304
  year: 2010
  ident: B23
  article-title: Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene.
  publication-title: Environ. Microbiol.
  doi: 10.1111/j.1462-2920.2009.02066.x
– volume: 9
  year: 2018
  ident: B46
  article-title: treatment of rheumatoid arthritis using combination of methotrexate and tripterygium glycosides tablets-A quantitative plasma pharmacochemical and pseudotargeted metabolomic approach.
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2018.01051
– volume: 14
  year: 2019
  ident: B50
  article-title: Effects of Debaryomyces hansenii treatment on intestinal mucosa microecology in mice with antibiotic-associated diarrhea.
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0224730
– volume: 371
  start-page: 1154
  year: 2021
  ident: B17
  article-title: Debaryomyces is enriched in Crohn’s disease intestinal tissue and impairs healing in mice.
  publication-title: Science
  doi: 10.1126/science.abd0919
– volume: 79
  start-page: 103
  year: 2020
  ident: B21
  article-title: Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population.
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/annrheumdis-2019-215743
– volume: 23
  year: 2021
  ident: B25
  article-title: Serum biomarker panel for the diagnosis of rheumatoid arthritis.
  publication-title: Arthritis Res. Ther.
  doi: 10.1186/s13075-020-02405-7
– volume: 74
  start-page: 1399
  year: 2015
  ident: B12
  article-title: Choline kinase inhibition in rheumatoid arthritis.
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/annrheumdis-2014-205696
– volume: 20
  start-page: 1411
  year: 2011
  ident: B29
  article-title: (1)H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.
  publication-title: Lupus
  doi: 10.1177/0961203311418707
– volume: 48
  start-page: 3077
  year: 2003
  ident: B34
  article-title: Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.11282
– volume: 51
  start-page: vi5
  year: 2012
  ident: B20
  article-title: ACR/EULAR 2010 rheumatoid arthritis classification criteria.
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kes279
– volume: 68
  start-page: 226
  year: 2019
  ident: B16
  article-title: Butyrate inhibit collagen-induced arthritis via Treg/IL-10/Th17 axis.
  publication-title: Int. Immunopharmacol.
  doi: 10.1016/j.intimp.2019.01.018
– volume: 38
  start-page: 4225
  year: 2011
  ident: B15
  article-title: Sphingosine-1-phosphate: A potential therapeutic target for rheumatoid arthritis.
  publication-title: Mol. Biol. Rep.
  doi: 10.1007/s11033-010-0545-9
SSID ssj0000402000
Score 2.4189029
Snippet Rheumatoid arthritis (RA) is a chronic inflammatory joint disease, which is associated with progressive disability, systemic complications, and early death....
ObjectiveRheumatoid arthritis (RA) is a chronic inflammatory joint disease, which is associated with progressive disability, systemic complications, and early...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 931431
SubjectTerms gut bacterial
gut fungus
metabolic pathway
metabolomics
Microbiology
rheumatoid arthritis
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUhJdBLaZuWbtsEFXIKOHglrWUdSklCQygkpwRyE_rMGnbtZO2F7r_vjK0NMYSechO25I8ZSfOeZb0h5EgIV85y47II9CMTqKxtmJMZk1FaJ0L0HHcjX10Xl7fiz93sbods01slA7YvUjvMJ3W7Wpz8fdz8ggH_ExknxFvwQOUsUD3GThSH-A9k6A0EJonj9Cqh_X5iRq6Up7XNl1uOolMv4j9CnuP_Jp8Foov35F1CkPR0cPkHshPqj2RvyCm52ScVOJ4O23lpE-kDoOOlocvQgbcXlaMpSTc1taf3644uq0GKaRmo37RQaKuWVjVNgqstxS-1dDUPa8C2TeUp9LV5r4T0idxc_L45v8xSPoXMCcG6LOYhd6osfeSSe3CQmTkAUFFwbkrHMQkH9xGKyisXeciV9ypGHgsXpS_4Z7JbN3X4QmgRCyMtA6onDSCwaOFiEaGSCiWzRZyQfGtG7ZLWOKa8WGjgHGh53Vteo-X1YPkJOX5q8jAIbfyv8hn65qkiamT3B5rVvU5DTpe25MXUWSFyCzOTMUZyNbW491aJ3LMJ-bH1rIYxhQslpg7NutUA6diMIxSeEDly-eiO4zN1Ne_VuVWBonj862s84jfyFt8aY-W0_E52u9U6HAAI6uxh37X_AbviCYo
  priority: 102
  providerName: Scholars Portal
Title The change of plasma metabolic profile and gut microbiome dysbiosis in patients with rheumatoid arthritis
URI https://www.proquest.com/docview/2732536153
https://pubmed.ncbi.nlm.nih.gov/PMC9623673
https://doaj.org/article/8b8361cb440b425aaa7391b7964940d2
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOilJH2QTdKiQk8FN7altaRjE7pdCukphb0JvaZryHqX2HvIv8-M7YT1pb30IoQt2_LMWPONJX3D2Gcpg57nLmSA4UcmiVnblUFlpQLlg0wQBe1GvvlVLX_Ln6v56iDVF60JG-iBB8Fdaq9FVQQvZe7RvpxzSpjC0w5KI_PYj77o8w6CqX4MprAoH6cxMQozqKY6eIwHy_KrEQgSiokj6vn6JyBzukTywOcsjtnrESzyb0MnT9iL1LxhL4f0kQ9vWY065sPOXb4FvkMgvHF8kzpU7F0d-JiPm7sm8j_7jm_qgXVpk3h8aLHS1i2vGz5yq7acfsry-3XaI4zd1pGjdNY96dE7drv4fnu9zMbUCVmQsuwyyFMejNYRhBIRdeHmAbESSCGcDoLybYgIWDXRBBApNzEaAAFVABUr8Z4dNdsmnTJeQeWULzGqUw7BFni8GRAqMkmXvoIZy5_EaMNIK07ZLe4shhckedtL3pLk7SD5GfvyfMlu4NT4W-Mr0s1zQ6LD7g-gkdjRSOy_jGTGPj1p1uLnQ3MirknbfWsRvZVzQah3xtRE5ZMnTs809bon4jYV8d-Js__RxXP2it6a3GKhL9hRd79PHxDvdP5jb9pY_lgVWN5I_QiE6gKI
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+change+of+plasma+metabolic+profile+and+gut+microbiome+dysbiosis+in+patients+with+rheumatoid+arthritis&rft.jtitle=Frontiers+in+microbiology&rft.au=Jing+Zhu&rft.au=Jing+Zhu&rft.au=Tingting+Wang&rft.au=Yifei+Lin&rft.date=2022-10-18&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-302X&rft.volume=13&rft_id=info:doi/10.3389%2Ffmicb.2022.931431&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_8b8361cb440b425aaa7391b7964940d2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-302X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-302X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-302X&client=summon